I am a
Home I AM A Search Login

Papers of the Week


January 27, 2023


Headache


http://www.ncbi.nlm.nih.gov/pubmed/36633118?dopt=Abstract

Eptinezumab for adolescents with chronic refractory headache: A retrospective chart review.

Authors

Abstract

To evaluate the safety and efficacy of eptinezumab for the treatment of chronic refractory headache in adolescents.